Potassium permanganate (CED0002301)

Record Information
Version1.0
Creation Date2009-06-19 21:58:21 UTC
Update Date2026-05-14 19:37:46 UTC
Accession NumberCHEM000968
Identification
Common NamePotassium permanganate
ClassSmall Molecule
Description
Potassium permanganate is an exogenous inorganic compound with the formula H8KMnO4 and an average molecular weight of 166.10 g/mol. It exists as a solid at room temperature. Potassium permanganate belongs to the alkali metal oxides, a subclass of alkali metal organides within the inorganic compounds. In industrial applications, it is used as a biocide, emulsifier, anti-caking agent, and as processing aids not otherwise specified. It is also used in the production of Acrylonitrile butadiene styrene plastics. The compound is found in or released from 20 recorded sources, including electrical and electronic equipment such as magnets, cores yokes or armatures, antennas, communication cables or conductors, and electric hearing aids. Other sources include building and construction materials like fencing, ceilings, and tents or canopies; household cleaning and consumer products such as pipe accessories and non electric simulated smoking devices; food and cookware related to the processing of meats and the preparation of vinegar, wine, or sparkling wine; and healthcare products, including antiseptics and disinfectants and unclassified therapeutic products. The recorded exposure route is topical. Potassium permanganate has three recorded protein targets. It targets cytoplasmic aconitate hydratase (ACO1) and mitochondrial aconitate hydratase (ACO2), where manganese inhibits aconitase to interfere with amino acid metabolism and increase citrate levels; this disruption of the catalytic [4Fe-4S] cluster produces iron regulary protein 1, altering cellular iron homeostasis. It also targets an unnamed protein by stabilizing iron regulatory protein 2, which may occur through direct competition for an iron-binding site. Finally, it binds to the major prion protein (PRNP), displacing copper and altering the conformation and redox chemistry of the complex in ways similar to those associated with prion disease.
Contaminant Type
  • Food Toxin
  • Human Neurotoxin
  • Industrial/Workplace Toxin
  • Inorganic Compound
  • Manganese Compound
  • Pollutant
  • Synthetic Compound
Chemical Structure
Synonyms
ValueSource
Tetrahydric acid manganese potassiumGenerator
Chemical FormulaH8KMnO4
Average Molecular Mass166.096 g/mol
Monoisotopic Mass165.944 g/mol
CAS Registry Number7722-64-7
IUPAC Nametetrahydrate manganese potassium
Traditional Nametetrahydrate manganese potassium
SMILESO.O.O.O.[K].[Mn]
InChI IdentifierInChI=1S/K.Mn.4H2O/h;;4*1H2
InChI KeyQWMFXVCKJMWTDN-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of inorganic compounds known as alkali metal oxides. These are inorganic compounds containing an oxygen atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen is an alkali metal.
KingdomInorganic compounds
Super ClassMixed metal/non-metal compounds
ClassAlkali metal organides
Sub ClassAlkali metal oxides
Direct ParentAlkali metal oxides
Alternative Parents
Substituents
  • Alkali metal oxide
  • Inorganic oxide
  • Inorganic salt
Molecular FrameworkNot Available
External DescriptorsNot Available
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearancePurple solid.
Experimental Properties
PropertyValue
Melting Point240°C
Boiling PointNot Available
Solubility64 mg/mL at 20°C [SHIU,WY et al. (1990)]
Predicted Properties
PropertyValueSource
logP0.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m³·mol⁻¹ChemAxon
Polarizability1.78 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-f3f81118cdd81f358694Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-f3f81118cdd81f358694Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-f3f81118cdd81f358694Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-d2bc8852555760a91952Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-d2bc8852555760a91952Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-d2bc8852555760a91952Not AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityManganese is a cellular toxicant that can impair transport systems, enzyme activities, and receptor functions. It primarily targets the central nervous system, particularily the globus pallidus of the basal ganglia. It is believed that the manganese ion, Mn(II), enhances the autoxidation or turnover of various intracellular catecholamines, leading to increased production of free radicals, reactive oxygen species, and other cytotoxic metabolites, along with a depletion of cellular antioxidant defense mechanisms, leading to oxidative damage and selective destruction of dopaminergic neurons. In addition to dopamine, manganese is thought to perturbations other neurotransmitters, such as GABA and glutamate. In order to produce oxidative damage, manganese must first overwhelm the antioxidant enzyme manganese superoxide dismutase. The neurotoxicity of Mn(II) has also been linked to its ability to substitute for Ca(II) under physiological conditions. It can enter mitochondria via the calcium uniporter and inhibit mitochondrial oxidative phosphorylation. It may also inhibit the efflux of Ca(II), which can result in a loss of mitochondrial membrane integrity. Mn(II) has been shown to inhibit mitochondrial aconitase activity to a significant level, altering amino acid metabolism and cellular iron homeostasis. (2)
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelChronic Inhalation: 0.0003 mg/m3 (1)
SymptomsManganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as “manganism”. (2)
TreatmentEYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
750.0mg/kgNot AvailableRatLD50OralexperimentalL326
500.0mg/kgNot AvailableMouseLD50SubcutaneousexperimentalT53
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
312Antiseptics and disinfectantsHealthcare, pharmaceuticals & veterinary productsNot Available
409Unclassified therapeutic productsHealthcare, pharmaceuticals & veterinary productsNot Available
495CeilingsBuilding & ConstructionNot Available
496FencingBuilding & ConstructionNot Available
503Tents Or CanopiesBuilding & ConstructionNot Available
506AntennasElectrical & Electronic EquipmentNot Available
510Communication Cables Or ConductorsElectrical & Electronic EquipmentNot Available
513Cores Yokes Or ArmaturesElectrical & Electronic EquipmentNot Available
516Electric Hearing AidsElectrical & Electronic EquipmentNot Available
527MagnetsElectrical & Electronic EquipmentNot Available
529Power CablesElectrical & Electronic EquipmentNot Available
533Sparking PlugsElectrical & Electronic EquipmentNot Available
536Superconductive Or Hyperconductive Conductors Cables Or Transmission LinesElectrical & Electronic EquipmentNot Available
537Television SystemsElectrical & Electronic EquipmentNot Available
540X Ray TubesElectrical & Electronic EquipmentNot Available
548Preparation Of VinegarFood, food processing & cookwareNot Available
549Preparation Of Wine Or Sparkling WineFood, food processing & cookwareNot Available
552Processing MeatsFood, food processing & cookwareNot Available
559Non Electric Simulated Smoking DevicesHousehold cleaning & consumer productsNot Available
562Pipe AccessoriesHousehold cleaning & consumer productsNot Available
579Manufacture Of Iron Or SteelIndustrial manufacturing & chemical processingNot Available
584BuoysMarine, shipping & aquacultureNot Available
589Life BuoysMarine, shipping & aquacultureNot Available
592Marine Propulsion Or SteeringMarine, shipping & aquacultureNot Available
594Ship HullsMarine, shipping & aquacultureNot Available
619Manicure PedicurePersonal care & cosmeticsNot Available
638Decorating TextilesTextiles, leather & furnishingsNot Available
643HeadwearTextiles, leather & furnishingsNot Available
652RopesTextiles, leather & furnishingsNot Available
653SewingTextiles, leather & furnishingsNot Available
655Slide FastenersTextiles, leather & furnishingsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Carbonic anhydrase 1 structureClick to view 3D structureCarbonic anhydrase 1P00915HumansPredicted (SEA)7784.92
Replicase polyprotein 1ab structureClick to view 3D structureReplicase polyprotein 1abK9N7C7Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012)Predicted (SEA)7784.61
Replicase polyprotein 1ab structureClick to view 3D structureReplicase polyprotein 1abP0DTD1SARS-CoV-2Predicted (SEA)7784.69
Amine oxidase [flavin-containing] B structureClick to view 3D structureAmine oxidase [flavin-containing] BP27338HumansPredicted (SEA)7784.69
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)7784.69
Click to view 3D structureProstaglandin G/H synthase 2Q05769Mus musculusPredicted (SEA)7784.61
Prostaglandin G/H synthase 1 structureClick to view 3D structureProstaglandin G/H synthase 1P23219HumansPredicted (SEA)7784.77
Carbonic anhydrase 2 structureClick to view 3D structureCarbonic anhydrase 2P00918HumansPredicted (SEA)7784.92
Click to view 3D structureGlyceraldehyde-3-phosphate dehydrogenaseP46406Oryctolagus cuniculusPredicted (SEA)6888.64
D(1A) dopamine receptor structureClick to view 3D structureD(1A) dopamine receptorP21728HumansPredicted (SEA)7784.69
Peregrin structureClick to view 3D structurePeregrinP55201HumansPredicted (SEA)7784.61
Bromodomain-containing protein 1 structureClick to view 3D structureBromodomain-containing protein 1O95696HumansPredicted (SEA)7784.46
Interleukin-18 structureClick to view 3D structureInterleukin-18Q14116HumansPredicted (SEA)7750.67
Toll-like receptor 9 structureClick to view 3D structureToll-like receptor 9Q9NR96HumansPredicted (SEA)7784.69
Alkaline phosphatase, tissue-nonspecific isozyme structureClick to view 3D structureAlkaline phosphatase, tissue-nonspecific isozymeP05186HumansPredicted (SEA)7784.69
Bromodomain and PHD finger-containing protein 3 structureClick to view 3D structureBromodomain and PHD finger-containing protein 3Q9ULD4HumansPredicted (SEA)7784.53
Click to view 3D structurePolyunsaturated fatty acid 5-lipoxygenaseP12527Rattus norvegicusPredicted (SEA)7784.69
Click to view 3D structureGlutamate--cysteine ligase catalytic subunitP48506HumansPredicted (SEA)6856.26
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansPredicted (SEA)7784.84
Interferon alpha/beta receptor 1 structureClick to view 3D structureInterferon alpha/beta receptor 1P17181HumansPredicted (SEA)7754.72
Aromatase structureClick to view 3D structureAromataseP11511HumansPredicted (SEA)7784.84
Click to view 3D structureGlucose-6-phosphate dehydrogenase-6-phosphogluconolactonaseQ9BHT9Plasmodium bergheiPredicted (SEA)7784.77
Cathepsin S structureClick to view 3D structureCathepsin SP25774HumansPredicted (SEA)7784.69
Dual specificity mitogen-activated protein kinase kinase 4 structureClick to view 3D structureDual specificity mitogen-activated protein kinase kinase 4P45985HumansPredicted (SEA)7784.61
Cathepsin K structureClick to view 3D structureCathepsin KP43235HumansPredicted (SEA)7784.61
Click to view 3D structureAconitate hydratase, mitochondrialQ99798HumansKnownManganese interferes with amino acid metabolism by inhibiting aconitase, resulting in an increase in citrate levels. It is also believed that this direct disruption of the catalytic [4Fe-4S] cluster of aconitase by manganese produces iron regulary protein 1, resulting in alterations in cellular iron homeostasis. (A159)
Cytoplasmic aconitate hydratase structureClick to view 3D structureCytoplasmic aconitate hydrataseP21399HumansKnownManganese interferes with amino acid metabolism by inhibiting aconitase, resulting in an increase in citrate levels. It is also believed that this direct disruption of the catalytic [4Fe-4S] cluster of aconitase by manganese produces iron regulary protein 1, resulting in alterations in cellular iron homeostasis. (A159)
Major prion protein structureClick to view 3D structureMajor prion proteinP04156HumansKnownManganese binds to the prion protein, altering its conformation, displacing copper, and altering the redox chemistry of the metal-protein complex. These changes are similar to those associated with prion disease. (A158)
Concentrations
Not Available
External Links
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkNot Available
Chemspider IDNot Available
ChEBI IDNot Available
PubChem Compound ID101611537
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References